Tag Archives: unanimously

SAG-AFTRA Board Votes Unanimously To “Strongly” Support The WGA In Its Contract Talks With AMPTP – Deadline

  1. SAG-AFTRA Board Votes Unanimously To “Strongly” Support The WGA In Its Contract Talks With AMPTP Deadline
  2. SAG-AFTRA Unanimously Votes to “Strongly” Support WGA in Its Contract Negotiations Hollywood Reporter
  3. SAG-AFTRA Board Speaks Out in Support of WGA, Urges Studios to ‘Remove Roadblocks to Fair and Equitable Wages’ Variety
  4. WGA’s Epic Two-Year Battle With Major Talent Agencies Set Stage For Showdown With Studios Over New Contract Deadline
  5. SAG-AFTRA Board Unanimously Supports WGA in Contract Talks With AMPAS TheWrap
  6. View Full Coverage on Google News

Read original article here

IDB directors unanimously recommend firing of Claver-Carone after ethics probe

Visitors walk past a screen with the logo of Banco Interamericano de Desarrollo (BID) at the Atlapa Convention Center in Panama City March 13, 2013. REUTERS/Carlos Jasso

Register now for FREE unlimited access to Reuters.com

WASHINGTON, Sept 22 (Reuters) – The Inter-American Development Bank’s board of directors voted unanimously on Thursday to recommend firing President Mauricio Claver-Carone after an independent ethics investigation found misconduct, three sources familiar with the vote said.

The recommendation throws the final decision regarding Latin America’s largest development bank to its senior-most body, the board of governors, which will vote from Friday through Tuesday, one of the sources said.

Claver-Carone did not immediately respond to a phone call or text message seeking comment.

Register now for FREE unlimited access to Reuters.com

A U.S. Treasury spokesperson declined to confirm the vote, but said the United States, the bank’s largest shareholder with 30% of its voting shares, supported Claver-Carone’s removal from office and wanted to see “swift resolution” by the governors.

“President Claver-Carone’s refusal to fully cooperate with the investigation, and his creation of a climate of fear of retaliation among staff and borrowing countries, has forfeited the confidence of the bank’s staff and shareholders and necessitates a change in leadership,” the spokesperson said.

Claver-Carone, in a statement in response to the Treasury said, “It’s shameful the U.S. commented to the press before notifying me and that it is not defending two Americans against what is clearly fabricated information.”

The bank’s 14 directors voted after four long days of discussions and an appearance by Claver-Carone, who had been in New York for meetings on the sidelines of the United Nations General Assembly this week.

Reuters reported on Wednesday that the board was nearing consensus on a vote to fire Claver-Carone.

Termination of Claver-Carone, a nominee of former U.S. President Donald Trump, requires a majority of the total voting power of the governing board. The bank’s three largest shareholders – the United States, Argentina and Brazil – together hold nearly 53% of the voting power. Claver-Carone took office in October 2020.

The governors are expected to approve the recommendation, said one of the sources.

Legal firm Davis Polk told the directors it found evidence to support whistleblower allegations that Claver-Carone had engaged in an intimate relationship with a subordinate and engaged in misconduct that violated the bank’s rules.

Investigators said they had uncovered evidence including a photograph of a hand-written contract on the back of a paper placemat, purportedly written and signed by Claver-Carone and the staffer, which stated, “we deserve absolute happiness” and a clause that stipulated any contract breach would result in “candle wax and a naughty box.”

U.S. officials were particularly concerned by Claver-Carone’s “behavior during the investigation, including his refusal to make available his IDB-issued work phone and other records,” a separate source familiar with the matter said.

They took issue with his “selective and misleading release of confidential information intended to taint the investigation and shape public opinion,” the source said. This had “undermined confidence in Claver-Carone’s trustworthiness and ability to lead a rules-based multilateral development institution,” the source added.

Claver-Carone also denied “direct evidence” that he had been in an undisclosed relationship with an IDB staff member who reported directly to him, and to whom he gave raises totaling more than 45% of base pay in less than one year, the source added.

U.S. officials felt Claver-Carone had created “an environment in which staff feared retaliation, including what appears to be actual retribution against senior and rank-and-file staff who participated fully and honestly in the investigation,” the source said.

U.S. Senator Patrick Leahy, who chairs the Senate Appropriations Committee, had strongly opposed Trump’s nomination of Claver-Carone as the first American to lead the bank, a job traditionally held by someone from Latin America.

“That tradition should be reinstated, with a person of the highest integrity and professionalism,” Leahy told Reuters.

Register now for FREE unlimited access to Reuters.com

Reporting by Andrea Shalal in Washington and Cassandra Garrison in Mexico City; Editing by Josie Kao and Stephen Coates

Our Standards: The Thomson Reuters Trust Principles.

Cassandra Garrison

Thomson Reuters

Mexico-based reporter focusing on climate change and companies with an emphasis on telecoms. Previously based in Santiago de Chile and Buenos Aires covering the Argentine debt crisis, the tussle for influence between the United States and China in Latin America and the coronavirus pandemic.

Read original article here

Mateusz Gamrot wins unanimously vs. Tsarukyan

LAS VEGAS – The main event between Mateusz Gamrot and Arman Tsarukyan was an incredible five rounds of action, proving exactly why this matchup deserved top billing of UFC on ESPN 38.

Both lightweight competitors entered the first main event of their UFC careers, with both men looking to make a statement on the big stage. When the dust settled after 25 minutes of high-paced action, the judges were unanimous in their decision, giving Gamrot (21-1 MMA, 4-1 UFC) the nod over Tsarukyan (18-3 MMA, 5-2 UFC).

Both fighters looked to establish their game early in the fight. Gamrot tried to get a takedown after grabbing a single leg and lifting it high, but Tsarukyan somehow managed to stay on his feet. A few moments later, Tsarukyan completed a beautiful takedown, and a few wild scrambles for position soon followed.

The action remained fast-paced in the second round. After a few opening exchanges, a thunderous kick from Tsarukyan to the body of Gamrot echoed throughout the UFC Apex. Tsarukyan tried to bring the fight to the ground again but was beautifully reversed by Gamrot. Another powerful kick from Tsarukyan landed to the body, as he seemed to get the better of Gamrot in the first two rounds.

The powerful striking offense of Tsarukyan continued early in the third round. He opened with another thunderous kick to the body and cracked Gamrot with a right hand a few moments later. Gamrot once again grabbed hold of a single leg but was unable to bring the fight to the mat.

A few moments later, though, he was able to grab hold of Tsarukyan and work his way to the back. Gamrot was unable to secure the position, but Tsarukyan worked free before any serious damage or submission attempts would occur. They returned to exchanging hard strikes until the round came to a close.

Gamrot came out firing in the fourth round and landed some big shots early. A spinning back fist from Tsarukyan landed and sent Gamrot down, but he was quick to recover. Another hard kick to the body scored for Tsarukyan as Gamrot shot for and completed a takedown. Gamrot took the back of his opponent and hunted for a submission, but the fight would go to the final round.

Tsarukyan landed a beautiful outside leg kick to sweep Gamrot off his feet early. Gamrot returned to his feet and kept the pressure high, shooting in for a beautiful takedown a moment later. After controlling Tsarukyan on the mat, they returned to the feet and continued to let the strikes fly. Gamrot looked for one more takedown to close out the fight. Tsarukyan was able to reverse position in the final seconds and land a few punches before the final horn sounded on this very entertaining main event.

All three official judges scored the fight 48-47 for Gamrot, notching the unanimous decision victory for the Polish fighter.

During his post-fight interview, Gamrot made it clear who he wants to mix it up with next.

“Now, I want to fight with Justin Gaethje,” said during his post-fight interview with Michael Bisping. “Justin Gaethje’s the most brutal guy in this division. I want to fight next with him.”

With the win, Gamrot makes it four straight after the lone setback of his professional career against Guram Kutateladze in 2020. Entering Saturday’s fight with consecutive stoppages against Scott Holtzman, Jeremy Stephens, and Diego Ferreira, the Poland-born fighter is now in a great position to take on the next level of competition in the lightweight division.

Tsarykyan entered holding the No. 14 spot in the USA TODAY SPORTS/MMA Junkie lightweight rankings, which likely means Gamrot will elevate from the honorable mentions to a ranked fighter in the next rankings update.

On the other side, the first UFC main event for Tsarukyan marks the second loss of his run with the promotion. He faltered in his UFC debut, dropping a unanimous decision to Islam Makhachev in 2019. Tsarukyan rebounded nicely as he went on to win five straight, including back-to-back stoppages against Christos Giagos and Joel Alvarez in his two previous outings.

Up-to-the-minute results of UFC on ESPN 38 include:

Mateusz Gamrot def. Arman Tsarukyan via unanimous decision (48-47, 48-47, 48-47)
Shavkat Rakhmonov def. Neil Magny via submission (guillotine choke) – Round 2, 4:58
Josh Parisian def. Alan Baudot via TKO (punches) – Round 2, 3:04
Thiago Moises def. Christos Giagos via submission (rear-naked choke) – Round 1, 3:05
Umar Nurmagomedov def. Nate Maness via unanimous decision (30-27, 30-26, 20-25)
Chris Curtis def. Rodolfo Vieira via unanimous decision (29-28, 29-28, 29-28)
Carlos Ulberg def. Tafon Nchukwi via TKO (punches) – Round 1, 1:15
Shayilan Nuerdanbieke def. T.J. Brown via unanimous decision (29-28, 29-28, 29-28)
Sergey Morozov def. Raulian Paiva via unanimous decision (29-28, 29-28, 29-28)
Cody Durden def. JP Buys via TKO (punches) – Round 1, 1:08
Mario Bautista def. Brian Kelleher via submission (rear-naked choke) – Round 1, 2:27
Vanessa Demopoulos def. Jinh Yu Frey via split decision (28-29, 29-28, 30-27)

Read original article here

Elon Musk’s $44B acquisition of Twitter unanimously approved by board

Twitter’s board has recommended unanimously that shareholders approve the proposed $44 billion sale of the company to billionaire and Tesla CEO Elon Musk, according to a regulatory filing Tuesday.

Musk reiterated his desire to move forward with the acquisition last week during a virtual meeting with Twitter employees, though shares of Twitter remain far below his offering price, signaling considerable doubt that it will happen.

Shares rose about 3% to $38.98 before the opening bell Tuesday, far short of the $54.20 per-share that Musk has offered for each share.

The company’s stock last reached that level on April 5 when it offered Musk a seat on the board before he had offered to buy all of Twitter.

In a filing with the US Securities and Exchange Commission detailing on Tuesday detailing a letter to investors, Twitter’s board of directors said that it “unanimously recommends that you vote (for) the adoption of the merger agreement.”

If the deal were to close now, investors in the company would pocket a profit of $15.22 for each share they own.

If the deal were to close now, investors in the company would pocket a profit of $15.22 for each share they own.
REUTERS

Read original article here

Canada lawmakers vote unanimously to label Russia’s acts in Ukraine as ‘genocide’

Canada’s Prime Minister Justin Trudeau speaks during Question Period in the House of Commons on Parliament Hill in Ottawa, Ontario, Canada April 27, 2022. REUTERS/Blair Gable

Register now for FREE unlimited access to Reuters.com

Register

April 27 (Reuters) – Canadian lawmakers voted unanimously on Wednesday to call Russia’s attacks in Ukraine a “genocide”, with members of parliament saying there was “ample evidence of systemic and massive war crimes against humanity” being committed by Moscow.

The Canadian House of Commons’ motion said war crimes by Russia include mass atrocities, systematic instances of willful killing of Ukrainian civilians, the desecration of corpses, forcible transfer of Ukrainian children, torture, physical harm, mental harm, and rape.

Earlier this month, Prime Minister Justin Trudeau said it was “absolutely right” for more and more people to describe Russia’s actions in Ukraine as genocide, supporting an accusation made by U.S. President Joe Biden a day earlier.

Register now for FREE unlimited access to Reuters.com

Register

Biden had said earlier in April that the Ukraine invasion amounted to genocide but had added that lawyers internationally would have to decide whether or not the invasion met the criteria for genocide.

Russia, which denies the genocide charges, calls its action in Ukraine a “special military operation” and said it was necessary because the United States was using Ukraine to threaten Russia. Moscow in turn accuses Ukraine of the genocide of Russian-speaking people, a charge that Ukraine dismisses as nonsense. read more

Canada is among a number of countries to have imposed sanctions on Russia after it invaded Ukraine on Feb. 24. On Wednesday, it imposed further sanctions on 203 individuals whom it says are complicit in Russia’s attempted annexation of certain areas of the Donbas region in eastern Ukraine.

Late on Wednesday, Canada also updated its travel advice for Moldova, citing the risk of armed conflict in Transnistria, a breakaway Russian-occupied part of Moldova in the west.

The government of Canada asked travelers to exercise a high degree of caution in Moldova and avoid all travel to Transnistria.

The Canadian government has also said it will change its sanctions laws to allow for funds or property seized or sanctioned from Russia to be paid out to help rebuild Ukraine or to those affected by Russia’s invasion. read more

Register now for FREE unlimited access to Reuters.com

Register

Reporting by Kanishka Singh in Washington; Editing by Sandra Maler and Jacqueline Wong

Our Standards: The Thomson Reuters Trust Principles.

Read original article here

F.D.A. Panel Unanimously Recommends Johnson & Johnson Booster Shots

WASHINGTON — A key federal advisory committee voted unanimously Friday to recommend Johnson & Johnson booster shots, most likely clearing the way for all 15 million people who got the company’s one-dose coronavirus vaccine to receive a second shot.

If the Food and Drug Administration and the Centers for Disease Control and Prevention accept the recommendation, as expected, boosters could be offered by late next week. But many committee members made clear that they believed Johnson & Johnson recipients might benefit from the option of a booster of the Pfizer-BioNTech or Moderna vaccine, something a top F.D.A. official said the agency was considering.

With a series of votes over the past month to recommend boosters for all three coronavirus vaccines used in the United States, the panel set aside significant divisions and skepticism about whether extra shots are needed and edged ever closer to the goal that President Biden laid out in August when he called for boosters for all adults.

Well over 100 million fully vaccinated people will be eligible for boosters if the F.D.A. and C.D.C. endorse the committee’s latest recommendations, even though some scientists say that the evidence supporting boosters remains weak and that it would have been wiser to focus on reaching the unvaccinated, including abroad.

Johnson & Johnson’s vaccine took a beating at Friday’s session, as did the F.D.A. for pushing for a decision without verifying all of the data that the company had submitted.

But the panel members appeared swayed by the argument that it would be unfair to deny Johnson & Johnson recipients an additional shot after endorsing boosters for recipients of the other two vaccines, especially in the face of evidence that Johnson & Johnson offers the weakest protection of the three.

“There is a public health imperative here, because what we’re seeing is that this is a group with overall lower efficacy than we have seen with the mRNA vaccines,” said Dr. Arnold Monto, the committee’s acting chairman and a professor of epidemiology at the University of Michigan School of Public Health. “So there is some urgency there to do something.”

In its second successive day of discussion on boosters, the group wavered on whether it would be wise to soon offer extra shots to younger recipients of the Pfizer and Moderna vaccines.

The government’s strategy now is to offer boosters of those vaccines to people 65 and older and to younger adults at high risk because of their medical conditions or jobs. No decision was made about broader eligibility criteria, but Dr. Monto and others described the issue as increasingly pressing.

The panel also seemed intrigued by preliminary data suggesting that Johnson & Johnson recipients may be better off with a booster shot from Moderna or Pfizer. Although no vote was taken, Dr. Peter Marks, who oversees the F.D.A.’s vaccine division, said regulatory action to allow boosters with a different vaccine was “possible.”

While some experts emphasized that the data was based on small groups of volunteers and short-term findings, others urged the F.D.A. to move quickly with what has fast become known as a mix-and-match approach, especially for recipients of Johnson & Johnson’s vaccine, which is much less widely available.

“I’m sold already,” said Dr. Mark Sawyer, an infectious disease specialist with the University of California San Diego School of Medicine. “We need flexibility and to improve access to everyone.”

Others said they worried that the public would end up bewildered if the government kept broadening the categories of people eligible for boosters and which vaccine could be used for extra shots.

“I hope we can do this in a way that doesn’t look like we’re changing rules all the time,” said Dr. Stanley Perlman, a professor of immunology at the University of Iowa.

Health officials and committee members suggested on Friday that the single-shot Johnson & Johnson vaccine had long been less protective. In a particularly biting critique, Dr. Amanda Cohn, a high-ranking C.D.C. medical officer, said a single dose of Johnson & Johnson’s vaccine offered less protection than two doses of the mRNA vaccines made by Pfizer or Moderna — a gap that would only grow if it remained a one-shot regimen while the other two-shot vaccines were followed by a booster.

Dr. Marks emphasized that the one-shot, easily stored Johnson & Johnson shot had served partly as an “outreach” vaccine — suggesting that refusing to offer a booster would disadvantage vulnerable populations.

To date, more than 104 million people in the United States have been fully vaccinated with Pfizer’s product, more than 69 million with Moderna’s and about 15 million with the Johnson & Johnson shot.

The government decided last month to offer booster shots of Pfizer’s vaccine to older Americans and other high-risk groups, and the panel voted Thursday to recommend the same approach for Moderna recipients. More than eight million people in the United States have already obtained Pfizer booster doses, and about 1.6 million have received third doses of Moderna’s, even though only Moderna recipients with immune deficiencies are officially eligible.

For Johnson & Johnson recipients, the committee recommended an additional shot for everyone who had received the vaccine — a reflection of its lower efficacy. Although the added injection was cast as a booster, some experts on the committee argued that the vaccine should have involved two doses from the start, separated by about two months.

Johnson & Johnson officials said a second dose given either two or six months after the first shot increased antibody levels, part of the immune response to vaccines. They also said that unlike Pfizer’s vaccine, Johnson & Johnson’s potency did not wane significantly over time.

The experts generally agreed that the protection conferred by a single dose was inadequate, but at least some were unconvinced that the second dose would bolster that protection significantly.

What to Know About Covid-19 Booster Shots

The F.D.A. authorized booster shots for a select group of people who received their second doses of the Pfizer-BioNTech vaccine at least six months before. That group includes: vaccine recipients who are 65 or older or who live in long-term care facilities; adults who are at high risk of severe Covid-19 because of an underlying medical condition; health care workers and others whose jobs put them at risk. People with weakened immune systems are eligible for a third dose of either Pfizer or Moderna four weeks after the second shot.

The C.D.C. has said the conditions that qualify a person for a booster shot include: hypertension and heart disease; diabetes or obesity; cancer or blood disorders; weakened immune system; chronic lung, kidney or liver disease; dementia and certain disabilities. Pregnant women and current and former smokers are also eligible.

The F.D.A. authorized boosters for workers whose jobs put them at high risk of exposure to potentially infectious people. The C.D.C. says that group includes: emergency medical workers; education workers; food and agriculture workers; manufacturing workers; corrections workers; U.S. Postal Service workers; public transit workers; grocery store workers.

It is not recommended. For now, Pfizer vaccine recipients are advised to get a Pfizer booster shot, and Moderna and Johnson & Johnson recipients should wait until booster doses from those manufacturers are approved.

Yes. The C.D.C. says the Covid vaccine may be administered without regard to the timing of other vaccines, and many pharmacy sites are allowing people to schedule a flu shot at the same time as a booster dose.

They were critical of the company’s data, saying F.D.A. regulators had challenged the sensitivity of one key test used to measure antibodies in people who received booster doses. They balked at the size of a study on Johnson & Johnson booster doses given at a sixth-month interval, based on only 17 volunteers. And they were clearly distressed to see slide after slide of data with the huge caveat: “Not verified by F.D.A.”

Dr. Archana Chatterjee, the dean of the Chicago Medical School, pointedly asked why the F.D.A. was pushing for a decision without a thorough review.

But she said later that she was convinced by the totality of the data, especially a C.D.C. report that found Johnson & Johnson was only 71 percent effective against hospitalization, compared with 88 percent for Pfizer and 93 percent for Moderna.

Ahead lie still more decisions for the F.D.A. and its outside experts. The group is set to meet again this month to discuss Pfizer-BioNTech’s request for authorization of a lower dose of its vaccine in children 5 to 11. Also pending is a decision on whether to authorize Moderna’s vaccine for adolescents — a move complicated by conflicting data about possible side effects involving the heart.

Regulators are expected to soon consider whether to allow people to get boosters of a different vaccine than what they initially got, which might produce a stronger immune response. “It’s real-world, practical questions that people want to know,” said Dr. Kirsten Lyke of the University of Maryland School of Medicine, who presented the results of the mix-and-match study to the committee.

Preliminary findings showed Johnson & Johnson recipients who got a booster with the Moderna vaccine saw their antibody levels rise 76-fold within 15 days, compared with only a fourfold rise if they received a booster shot of Johnson & Johnson. A Pfizer-BioNTech booster raised antibody levels in Johnson & Johnson recipients 35-fold.

The trial only looked at antibody levels, which on their own are an insufficient measure of how well different combinations of vaccines would protect people.

Dr. Cohn, the C.D.C. official, suggested that the F.D.A. could include language in its booster authorizations that would allow switches between brands.

“From a public health perspective, there’s a clear need in some situations for individuals to receive a different vaccine,” she said. She said that some people might not have access to the same vaccine again, or might have increased risks of some side effects from using it again as a booster.

Dr. Ofer Levy, an infectious disease physician at Boston Children’s Hospital, said the F.D.A. should act because some people were already seeking boosters on their own.

“In the real world, all these kinds of combinations or extra boosters are already happening,” he said. “We can’t hide from it, and I do think we need to give guidance to the public.”

At the same time, the government needs “to make sure that we don’t confuse the public even more than we are already,” said Dr. Jeannette Lee, a professor at the University of Arkansas for Medical Sciences.

Read original article here

Texas pardons board votes unanimously to recommend posthumous pardon for George Floyd

An application for the pardon was filed in April on behalf of Floyd and his surviving family. In the application, Allison Mathis of the Harris County Public Defender’s Office said the request was filed because the arresting officer in Floyd’s case, Gerald Goines, “manufactured the existence of confidential informants to bolster his cases against innocent defendants.”
“We lament the loss of former Houstonian George Floyd and hope that his family finds comfort in Monday’s decision by the Texas State Board of Pardons and Paroles to recommend clemency for a 2004 conviction involving former Houston Police Department Officer Gerald Goines,” Kim Ogg, the Harris County district attorney, said in a statement.

The ultimate decision on whether to grant Floyd clemency rests with Gov. Greg Abbott, Ogg said. CNN has reached out to the governor’s office for comment on whether a pardon will be issued.

Goines arrested Floyd on February 5, 2004, alleging at the time that Floyd possessed crack cocaine “and that Floyd had provided the drugs to an unnamed ‘second suspect’ who had agreed to sell the drugs to the undercover Goines. The ‘second suspect’ was not arrested, Goines noted in his offense report, “in a [sic] attempt to further the narcotic trafficing [sic] in this area.”

Goines’ attorney, Nicole DeBorde, told CNN in April, “We stand by the original case. We certainly sympathize with Mr. Floyd’s cause, but that doesn’t change the fact that his former conviction was a legitimate one.”

In 2019, Goines was involved in a high-profile case known as the Harding Street killings, in which he obtained a warrant for a “no-knock” raid from a municipal judge under false pretenses, Ogg told CNN. The raid left two people dead and five police officers injured.

Goines, a 35-year law enforcement veteran, was indicted on two charges of felony murder and tampering with a government record, Ogg said.

DeBorde, Goines’ attorney, told CNN her client pleaded not guilty to all charges.

CNN’s Jennifer Henderson contributed to this report.

Read original article here

STB UNANIMOUSLY REJECTS CN-KCS VOTING TRUST (Updated With CP and CN Statements)


Written by

William C. Vantuono, Editor-in-Chief

STB Chairman Martin J. Oberman

The United States Surface Transportation Board—as expected by many industry observers and financial analysts—on Aug. 31, 2021, by unanimous vote, rejected the CN-Kansas City Southern voting trust, effectively killing the merger, and opening the door for Canadian Pacific to re-engage with KCS on the CPKC (“Canadian Pacific Kansas City”) deal it struck with KCS on March 21, albeit with a sweetened offer.

“The Board finds that the proposed use of a voting trust in the context of the impending control application does not meet the standards under the current merger regulations and therefore denies the applicants’ motion for authorization to establish and use the proposed voting trust,” STB said in Docket No. FD 36514 (downloadable below). “The Board has determined that the proposed voting trust is not consistent with the public interest standard under the Board’s merger regulations.”

Those merger regulation are the “new” ones established in 2001—new because they have thus far never been applied, and will not be in this case, provided that the CN-KCS deal is rejected by KCS shareholders on Sept. 3. A CP-KCS combination, if the two Class I’s rekindle their relationship, would be considered under the STB’s “old” (pre-2001) merger rules, with a CP-KCS voting trust pre-approved, and managed by the trustee—former KCS CEO Dave Starling—appointed by both Canadian railroads.

There were many factors STB considered in its decision. Several in particular stand out:

• “Many rail users said they are concerned that the 45% price premium CN has offered to acquire KCS, and the related debt burden it will incur to finance the purchase, would create incentives for CN to charge higher prices to current customers or decrease investment in CN’s network in order to improve financial performance; these commenters note that these incentives would arise whether or not a divestiture was ultimately required, because CN would be unable to rely on any of the merger “synergies” it plans for several years. They also argue that these risks would be increased if divestiture were required, both because CN would be unlikely to obtain a price that approaches the premium it paid for KCS, and because the economic climate in 2023 may be less favorable.”

 • The Department of Justice, which has a statutory right to intervene through the Attorney General in Class I merger proceedings … filed comments on May 14, 2021, stating that the proposed acquisition ‘raises sufficient competition concerns on first blush that the CN should be prohibited from using a voting trust.’ DOJ argues that, even though the terms of the CN and CP voting trusts are similar, ‘the Board has good reason to hold CN’s proposed voting trust to a higher bar,’ because the diminished competitive incentives that arise from the unity in ownership created by a voting trust are heightened due to the direct parallel competition and overlapping routes in the CN and KCS networks. DOJ asserts that these threats to competition would be present immediately after the voting trust is consummated, and states that ‘[t]hese specific competitive concerns presented by CN’s proposed transaction magnify the general risks associated with voting trusts’ described in DOJ’s filing in Docket No. FD 36500, such that its concerns about the use of a voting trust in the proposed CP transaction ‘apply with greater force to CN’s proposed acquisition of KCS.’ 

• “DOJ also asserts that ‘[l]ike any other buyer that competes with its target, CN voluntarily assumed the risks associated with the regulatory review of the proposed transaction.’ DOJ argues that there are viable alternatives to the use of a voting trust that ‘better protect both firms’ incentives to compete vigorously’ while addressing regulatory risk, and asserts it is ‘particularly important to protect these incentives to compete where, as here, CN and KCS appear to compete head to head on multiple parallel routes.’ DOJ contends that ‘a strategic buyer should not be permitted to structure the deal in a manner that could give rise to anticompetitive effects simply because the alternative would be more expensive.’”

• “Applicants have not demonstrated that their use of a voting trust would have public benefits, and further finds that there are public interest risks to competition and divestiture associated with the use of a voting trust in the context of the impending control application. Accordingly, the Board finds that the use of a voting trust would not be consistent with the public interest and will deny Applicants’ motion for voting trust approval.”

• “Prevention of Unlawful Control: Applicants’ motion and supporting documents fail to address the subject of communications between KCS and CN during the trust period … Applicants make no provision for  … an explicit acknowledgement that the trustee is responsible for implementing measures to monitor and assure that the information exchanges that occur between the carriers do not compromise the independent management and operation of the acquired company (Kansas City Southern) during the duration of the voting trust … Regardless of the deficiency described above regarding CN-KCS communications, which might otherwise be curable, the Board has determined that Applicants’ proposed use of a voting trust, in the context of their impending control application, is not consistent with the public interest.”

• “Applicants contend that they have shown that the proposed voting trust ‘would achieve substantial public benefits’ while presenting ‘no risk of harm to the public interest,’ and that their showing ‘overwhelmingly supports approval’ under the public interest standard established in 49 C.F.R. § 1180.4(b)(4)(iv) … [T]he Board finds that neither claim is persuasive and that it would not be consistent with the public interest to allow CN to acquire and place KCS into trust during the pendency of this control proceeding.”

• “Applicants’ … contention that a voting trust would serve the public interest by allowing CN and CP to compete to acquire KCS ‘on an equal footing’ fails to recognize two critical and related points. First … the two transactions are substantially different: The proposed CP-KCS transaction … is an end-to-end merger, whereas, here, the CN system overlaps with that of KCS. Second, the Board—after considering the overlapping routes and presently existing direct competition—agreed with CN’s commitment to file an application under the current regulations and thus placed the CN-KCS transaction under a different regulatory standard with respect to both approval of the transaction and use of a voting trust. These differences, particularly the heightened regulatory standards the CN-KCS proposal must meet, necessarily place CN’s proposal to acquire KCS on a different footing from Canadian Pacific’s proposal. Thus, the use of a voting trust for the CN-KCS transaction raises different and greater risks with respect to both competition and divestiture. Accordingly, Applicants’ contentions that approval is required because CN and CP are ‘two similarly situated potential acquirers, or because they may be ‘identically situated’ with respect to some factors pertinent to the Board’s consideration of a voting trust … are misplaced. To the extent the CN-KCS proposal is not on an ‘equal footing’ with the CP-KCS proposal, that is attributable to the differences in the governing regulatory standards and the proposed transactions themselves, and not the Board’s prior approval of a CP-KCS voting trust.”

• “Applicants’ related arguments—that the use of the voting trust ‘is crucial to place the CN-KCS transaction on a level playing field for KCS shareholders,’ and that ‘it would be fundamentally unfair for the Board to approve CP’s voting trust, and then to deny CN’s identical voting trust’ because ‘[t]his would effectively override KCS’s judgment about its preferred merger partner’—are equally misplaced. To be clear, the Board’s responsibility under these circumstances is to assess whether the proposed CN-KCS voting trust is ‘consistent with the public interest,’ … and not—as Applicants appear to argue—help private parties realize their transactional preferences regardless of that broader assessment. Like any rail carrier (or other bidder in a potential acquisition that requires regulatory review), CN had a choice about how to structure its offer; CN voluntarily assumed the risk that the voting trust might be rejected when it chose to make a voting trust an essential element of its offer, knowing that a CN-KCS proposed transaction presents geographic network overlap and that voting trusts must meet a heightened public interest standard for approval in major control proceedings under the current regulations. Similarly, KCS, as the potential acquiree, is in a position to weigh (among other things) the potential benefit of shorter or less burdensome regulatory review against potential benefits that a different proposal (with more demanding regulatory requirements) might provide, such as a higher purchase price … Accordingly, it is neither ‘fundamentally unfair’ nor does it improperly ‘override KCS’s judgment about its preferred merger partner’ to deny approval for the CN-KCS voting trust. KCS was not only aware of the regulatory risks associated with the proposed use of a voting trust in a CN-KCS  transaction; it also appears to have engaged in negotiations with CN on that very issue before deciding to accept CN’s offer.”

• “The explanations Applicants offer to support their final claim—that a voting trust is necessary to serve the ‘undoubted’ public interest in ‘ensuring that merger decisions are made by capital markets, not by the Board’—also lack merit. As discussed above, their arguments that a voting trust is ‘essential’ to a competitive bid that would allow their transaction to go forward, and to respect KCS’s choice of a merger partner, are both unpersuasive as factual matters … Applicants essentially claim that there is a public benefit in allowing them to use a voting trust because they should be able to make merger decisions unfettered by regulatory requirements or uncertainty, or specific analysis of a transaction that may be distinguishable from that of other transactions. The Board disagrees. Applicants have failed to explain how their request to allow CN to acquire and place KCS into a voting trust would result in any material public benefit. … [P]lacing KCS in trust would insulate KCS and CN from the regulatory risks and uncertainties associated with the heightened scrutiny that the proposed transaction would face under the current major merger regulations and the heightened possibility of divestiture—an advantageous scenario for KCS shareholders and CN at the expense of the public interest in mitigating risks to competition and the stability of the rail network … Further, negotiation choices by private parties cannot control agency decision-making. CN’s choice to make a voting trust an element of its offer to acquire KCS cannot nullify an established regulatory standard that requires the Board to conduct an independent assessment of public interest considerations pertinent to the proposed use of a voting trust in a particular case.”

• “[T]he competition between CN and KCS via overlapping routes is apparent at this juncture, as the Applicants acknowledge for at least one route, and the potential harms to this competition constitute an important reason the transaction is subject to the new regulations and, in turn, the heightened voting trust standard. These are the exact harms (among others) the Board is tasked with preventing, or at least minimizing, as part of its public interest review.  … For these reasons, in light of the overlap in Applicants’ networks, the Board finds that the use of the proposed voting trust creates competitive risks that are inconsistent with the public interest.” 

• “The Board emphasizes that it is not making a final determination regarding the extent of these competitive issues or whether they can be resolved. It is simply finding that, in view of the heightened scrutiny that both the use of a voting trust and the proposed transaction face under the current major merger regulations, it would not be in the public interest to allow CN to own KCS until the competitive issues have been thoroughly examined.”

• “The possibility that a CN-KCS transaction would trigger downstream effects and, potentially, further consolidation initiatives, creates additional risks and uncertainties during the voting trust period.”

“[T]he Board finds that Applicants have not demonstrated that their use of a voting trust would be consistent with the public interest,” STB said in its conclusion. “Applicants have shown no benefit from the use of a voting trust to stakeholders other than KCS and CN. At the same time, the use of a voting trust, in the context of the impending control application, would raise risks that threaten to undermine the public interests the Board considers … These risks can be avoided, without preventing Applicants from continuing to seek approval for their merger plans, by not allowing the acquisition to take place until regulatory review of the transaction—the first to be considered under the Board’s current major merger regulations—is complete. 

“It is ordered: Applicants’ joint motion for approval to use a voting trust is denied.”

Next Moves

As analyst Wolfe Research—without speculating on whether the voting trust would be approved or rejected— noted on Aug. 30, there are now two possible scenarios: “CN could try and raise the bid for KCS yet again to try to convince KCS to wait out full merger approval to get a higher price. Alternatively, if the voting trust is rejected and CN doesn’t raise the bid again, it seems likely to us that KCS shareholders will vote against the merger with CN, and then KCS can re-engage with CP. In that scenario, KCS would owe CN a $700 million breakup fee. Given the [Aug. 30 Securities and Exchange Commission Schedule 13D] activist filing from TCI Fund Management Ltd. [which now is a ‘beneficial owner’ of CN with 5.2% of the company’s shares], it now seems less likely to us that CN would raise the bid again if the voting trust is rejected.”

CP Back in Play—As Expected

CP President and CEO Keith Creel, Railway Age’s 2021 Railroader of the Year..

Canadian Pacific—patiently waiting in the wings for the other shoe to drop, with a $300 per share offer, an approved voting trust and a potential merger that would be evaluated under the STB’s pre-2001 rules—issued a statement basically saying to KCS, “We were right. Forget CN. Let’s do this deal.”

CP called the STB’s denial of the CN-KCS voting trust “the right one for rail shippers, the freight rail industry and the North American economy. The STB recognized the trust was not consistent with the public interest and the CN-KCS combination is anticompetitive.”

“The STB decision clearly shows that the CN-KCS merger proposal is illusory and not achievable,” said Keith Creel, CP President and CEO. “Knowing this, we believe the August 10 CP offer to combine with KCS, which recognizes the premium value of KCS while providing regulatory certainty, ought to be deemed a superior proposal. Today, we have notified the KCS Board of Directors that our August 10 offer still stands to bring this once-in-a lifetime partnership together. CP has always maintained that the CN-KCS combination and the proposed CN voting trust is not in the public interest. Hundreds of rail shippers, community leaders, elected officials and other stakeholders have voiced those same concerns and today, the STB agreed.”

“CP-KCS is the only true end-to-end Class I combination that serves the public interest, preserving and enhancing competition for customers and enabling a stronger North American rail network connecting Canada, the United States and Mexico,” CP said, reiterating the points it has made in countless statements. “CP-KCS is a superior combination that has a path to approval and deal certainty for the KCS shareholders. As previously announced, CP continues to pursue its application process for a potential acquisition of KCS so that the STB can review the pro-competitive CP-KCS combination without undue delay. Importantly, the STB has already approved CP’s use of a voting trust and affirmed KCS’ waiver from the new rail merger rules it adopted in 2001 because a CP-KCS combination is truly end-to-end, pro-competitive, and the only viable Class I combination.”

CP has filed a proxy statement asking stockholders to vote “AGAINST” the proposed CN-KCS combination at the KCS Sept. 3 stockholders meeting so that KCS stockholders “are not locked into the CN-KCS deal and unable to consider other, better, options. That includes CP’s Aug. 10 offer submitted to KCS. A vote to ‘ABSTAIN’ and vote ‘AGAINST’ are essentially the same since they both withhold approval of the CN merger proposal.”

CP pointed to the STB’s take on competitive overlap, quoting from the decision: “The competitive overlap in [CN and KCS’s] networks is not limited to, and extends beyond, the Baton Rouge-New Orleans corridor. Applicants operate parallel lines through the central portion of the United States and compete for north-south traffic on these lines, particularly where KCS’s network parallels the section of CN’s network that CN acquired from Illinois Central (IC) in 1999 … The new regulations that apply to major transactions such as this one go beyond preserving competitive options at two-to-one locations and seek to protect product and geographic competition … The two transactions are substantially different: The proposed CP-KCS transaction … is an end-to-end merger, whereas, here, the CN system overlaps with that of KCS.”

CN: What Else Can It Say at This Point?

CN President and CEO JJ Ruest

 CN issued the following statement at approximately 10:30 PM on Aug. 31:

“We are disappointed in the STB’s decision regarding the joint voting trust application filed by CN and KCS. We are evaluating the options available to us in light of the STB’s decision. 

“We remain confident that our pro-competitive, end-to-end combination is in the public interest and that it would offer unparalleled opportunities and benefits for customers, employees, the environment and the North American economy. The combined company would create the premier railway for the 21st century and establish seamless single-line service from Canada, through the United States and into Mexico. 

“Since the proposed combination with KCS was announced, we have been encouraged by the overwhelming support from both companies’ customers, employees, local communities and shareholders. We continue to believe that the combination of CN and KCS would enhance competition, expand North American trade and power economic prosperity, provide new and faster routes, increase supply chain efficiency and deliver other benefits to the public good.” 

Categories: Class I, Freight, Freight Forecasting, Intermodal, News, Regulatory, Short Lines & Regionals, Switching & Terminal
Tags: Breaking News, Canadian Pacific, CN, Kansas City Southern, KCS, STB, Surface Transportation Board

Read original article here

Clark County Commission unanimously votes in favor of new mask mandate

LAS VEGAS (KTNV) — The Clark County Commission held an emergency meeting today in response to the rising number of COVID-19 cases in the county and unanimously voted in favor of an employee mask mandate.

The meeting started with passionate pleas from community members on both sides of the debate, followed by testimony from the Southern Nevada Health District.

RELATED: Clark County commissioners discuss COVID mitigation amid rising case numbers

After commissioners asked questions of the SNHD representative they debated the options available to them before voting on a motion brought by Commissioner Jim Gibson.

The motion stated that all employers in Clark County must mandate their employees to wear a mask when in public spaces of the building. Those in enclosed offices or cubicles do not have to wear a mask when in their enclosed areas but must wear a mask when out in the public spaces.

This new mandate will take effect at 11:59 p.m. on July 21 and run through August 17 when the commissioners will meet again.

REPLAY THE FULL MEETING HERE:

appId : '1484209651881509',

xfbml : true, version : 'v2.9' }); }; (function(d, s, id){ var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) {return;} js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js"; js.async = true; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));

Read original article here

After memorable regular season for Edmonton Oilers, Connor McDavid wins Hart Trophy unanimously as NHL’s MVP

Edmonton Oilers star Connor McDavid won the Hart Trophy as NHL most valuable player, becoming only the second player in the 97-year history of the award to win it unanimously.

McDavid placed first on all 100 ballots from the Professional Hockey Writers Association. Previously, only Wayne Gretzky won the Hart unanimously back in 1981-82, also with the Oilers.

Toronto Maple Leafs center Auston Matthews earned 69 second-place votes and placed second in the voting to McDavid. Colorado Avalanche center Nathan MacKinnon was third. McDavid also won the Ted Lindsay Award as the NHLPA’s most outstanding player. Matthews and Pittsburgh Penguins center Sidney Crosby were the other finalists for the Lindsay.

McDavid led the NHL with 105 points in 56 games. His 1.88 points per game average was the 22nd best in NHL history and the highest since Mario Lemieux’s 2.30 points per game average in 1995-96. McDavid led the NHL with 72 assists as well.

This was his second Hart Trophy and third Lindsay Award win, coupled with his third NHL scoring title. McDavid’s Hart Trophy win followed that of teammate Leon Draisaitl last season. The Oilers are the first team with different Hart Trophy winners in consecutive seasons since the Boston Bruins in 1968-69 (Phil Esposito) and 1969-70 (Bobby Orr).

In other awards voting, Vegas Golden Knights goalie Marc-Andre Fleury won his first Vezina Trophy as the NHL’s top goalie. It was the first time Fleury had been nominated for the award after 17 seasons in the NHL with the Vegas Golden Knights and the Pittsburgh Penguins. He was named on 30 of the 31 ballots and received 14 first-place selections from the NHL’s general managers, who vote on this award.

Tampa Bay Lightning goalie Andrei Vasilevskiy, who was nominated for the award for four straight seasons and won the Vezina in 2019, finished second, just 10 points behind Fleury. Colorado Avalanche goalie Philipp Grubauer was third.

“Having a good team in front of me has always helped,” said Fleury, who shared the Jennings Trophy with Robin Lehner after Vegas allowed the fewest goals in the regular season. “But I just love the game. Have a lot of passion. I’m lucky to do what I like to do.”

New York Rangers defenseman Adam Fox captured the Norris Trophy as the NHL’s best defenseman, finishing ahead of Cale Makar of the Colorado Avalanche and Victor Hedman of the Tampa Bay Lightning, who was nominated for the fifth year in a row. Fox was named on 99 of 100 ballots, including 40 first-place selections. Makar was the top choice of 31 voters.

Fox is the second defenseman in NHL history to win the Norris in his first or second NHL season, after Orr won for the Boston Bruins in 1967-68. This was Fox’s second NHL season, both with the Rangers. The 23-year-old Fox was first among defensemen in assists (42) and second in points (47).

Minnesota Wild winger Kirill Kaprizov bested Dallas Stars forward Jason Robertson and Carolina goalie Alex Nedeljkovic for rookie of the year honors. The Minnesota winger had 51 points in 55 games, including 27 goals.

There was a bit of controversy around his candidacy, as some bristled at his age (24) and six seasons playing in Russia’s Kontinental Hockey League before joining the NHL. But that wasn’t reflected in the voting: Kaprizov was a near-unanimous winner, receiving 99 of 100 first-place votes and one second-choice selection. He earned the highest percentage of first-place votes in Calder balloting since 1992-93, when Winnipeg Jets forward Teemu Selanne was the top choice on all 50 ballots.

The NHL previously announced several awards prior to Tuesday’s telecast. Florida Panthers center Aleksander Barkov won the Selke Trophy as best defensive forward. Carolina Hurricanes defenseman Jaccob Slavin captured the Lady Byng Memorial Trophy for gentlemanly play. Rod Brind’Amour of the Carolina Hurricanes won the Jack Adams Award for coach of the year. Lou Lamoriello of the New York Islanders snagged the Jim Gregory General Manager of the Year Award for the second straight season.

Boston Bruins center Patrice Bergeron won the Mark Messier NHL Leadership Award, while Nashville Predators goalie Pekka Rinne was given the King Clancy Trophy who best exemplifies leadership qualities on and off the ice. Philadelphia Flyers forward Oskar Lindblom was named the winner of the Bill Masterton Memorial Trophy for perseverance and dedication to hockey.

The Professional Hockey Writers Association votes on the Hart, Norris, Calder, Selke and Lady Byng awards. Because the NHL realigned its teams and only played within its four divisions, the PHWA reduced its voting body to 100 members for the 2020-21 season: 20 voters for each division and 20 at-large voters.

Read original article here